State Legal Restrictions and Prescription-Opioid Use among Disabled Adults.

BACKGROUND In response to rising rates of opioid abuse and overdose, U.S. states enacted laws to restrict the prescribing and dispensing of controlled substances. The effect of these laws on opioid use is unclear. METHODS We tested associations between prescription-opioid receipt and state controlled-substances laws. Using Medicare administrative data for fee-for-service disabled beneficiaries 21 to 64 years of age who were alive throughout the calendar year (8.7 million person-years from 2006 through 2012) and an original data set of laws (e.g., prescription-drug monitoring programs), we examined the annual prevalence of beneficiaries with four or more opioid prescribers, prescriptions yielding a daily morphine-equivalent dose (MED) of more than 120 mg, and treatment for nonfatal prescription-opioid overdose. We estimated how opioid outcomes varied according to eight types of laws. RESULTS From 2006 through 2012, states added 81 controlled-substance laws. Opioid receipt and potentially hazardous prescription patterns were common. In 2012 alone, 47% of beneficiaries filled opioid prescriptions (25% in one to three calendar quarters and 22% in every calendar quarter); 8% had four or more opioid prescribers; 5% had prescriptions yielding a daily MED of more than 120 mg in any calendar quarter; and 0.3% were treated for a nonfatal prescription-opioid overdose. We observed no significant associations between opioid outcomes and specific types of laws or the number of types enacted. For example, the percentage of beneficiaries with a prescription yielding a daily MED of more than 120 mg did not decline after adoption of a prescription-drug monitoring program (0.27 percentage points; 95% confidence interval, -0.05 to 0.59). CONCLUSIONS Adoption of controlled-substance laws was not associated with reductions in potentially hazardous use of opioids or overdose among disabled Medicare beneficiaries, a population particularly at risk. (Funded by the National Institute on Aging and others.).

[1]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[2]  R. Deyo,et al.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.

[3]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[4]  J. Turner,et al.  Opioid dosing trends and mortality in Washington State workers' compensation, 1996-2002. , 2005, American journal of industrial medicine.

[5]  M. Ingber,et al.  Diagnosis-Based Risk Adjustment for Medicare Prescription Drug Plan Payments , 2007, Health care financing review.

[6]  C. Marco,et al.  A statewide prescription monitoring program affects emergency department prescribing behaviors. , 2010, Annals of emergency medicine.

[7]  Bradley C Martin,et al.  Emergency department visits among recipients of chronic opioid therapy. , 2010, Archives of internal medicine.

[8]  B. Psaty,et al.  Opioid Prescriptions for Chronic Pain and Overdose , 2010, Annals of Internal Medicine.

[9]  S. Schnoll,et al.  Do prescription monitoring programs impact state trends in opioid abuse/misuse? , 2012, Pain medicine.

[10]  M. Valenstein,et al.  Association Between Opioid Prescribing Patterns and Opioid Overdose-Related Deaths , 2012 .

[11]  T. Brennan,et al.  Abusive prescribing of controlled substances--a pharmacy view. , 2013, The New England journal of medicine.

[12]  C. Cunningham,et al.  Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010. , 2014, JAMA internal medicine.

[13]  L. Paulozzi,et al.  Decline in Drug Overdose Deaths After State Policy Changes — Florida, 2010–2012 , 2014, MMWR. Morbidity and mortality weekly report.

[14]  Dana Goldman,et al.  Opioid prescribing by multiple providers in Medicare: retrospective observational study of insurance claims , 2014, BMJ : British Medical Journal.

[15]  J. Skinner,et al.  Prescription Opioid Use Among Disabled Medicare Beneficiaries: Intensity, Trends, and Regional Variation , 2014, Medical care.

[16]  Tamara M Haegerich,et al.  What we know, and don't know, about the impact of state policy and systems-level interventions on prescription drug overdose. , 2014, Drug and alcohol dependence.

[17]  Eric L. Sevigny,et al.  Assessing the effects of medical marijuana laws on marijuana use: the devil is in the details. , 2015, Journal of policy analysis and management : [the journal of the Association for Public Policy Analysis and Management].

[18]  G. D’Onofrio,et al.  Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial. , 2015, JAMA.

[19]  Leonard J Paulozzi,et al.  Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013. , 2015, Morbidity and mortality weekly report. Surveillance summaries.

[20]  Daniel W Webster,et al.  Effect of Florida's Prescription Drug Monitoring Program and Pill Mill Laws on Opioid Prescribing and Use. , 2015, JAMA internal medicine.

[21]  Emma B. Saxon.  Multiple comparisons , 2015, BMC Biology.

[22]  Richard C Dart,et al.  Trends in opioid analgesic abuse and mortality in the United States. , 2015, The New England journal of medicine.

[23]  S. Weiner,et al.  Mandatory use of prescription drug monitoring programs. , 2015, JAMA.

[24]  Angela Kilby,et al.  Opioids for the Masses: Welfare Tradeoffs in the Regulation of Narcotic Pain Medications , 2016 .

[25]  Grant T Baldwin,et al.  Relationship between Nonmedical Prescription-Opioid Use and Heroin Use. , 2016, The New England journal of medicine.